Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease

This study has been completed.
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center Identifier:
First received: September 9, 2005
Last updated: December 21, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2008
  Primary Completion Date: July 2003 (Final data collection date for primary outcome measure)